Jacques Raynaud is Honorary President of the Foundation ARC and Knight of the French Legion of Honor.

Previously, Jacques Raynaud spent most of his career in the pharmaceutical industry. After four years of research on behalf of Nestlé (Switzerland) and Esso Research (USA), he joined Roussel Uclaf in 1969 to become a member of the Directorate of Hoechst Marion Roussel France in 1998. Following the merger with Aventis he was appointed to head the Romainville Research Centre and joined the International Committee in Research and Development of Aventis. At the time of the merger with Sanofi he joined, as Sr VP, Business Transformation for Drug Innovation and Approvals.

Jacques Raynaud is Senior adviser to WIN Strategy, Science and Fundraising